Basic robotic surgery aims to maintain erections – how it works

Goodbye, flop wind!

Prostate cancer is the most common cancer in men in the US, in addition to skin cancer. About 13% of male Americans will take it – and treatment often comes with the risk of erectile dysfunction.

The relief is coming-the first double-robotic surgery in the world to remove a prostate gland last month in Texas. This basic approach aims to maintain the nerves that control the erectile function.

“We have a magnetic technology that enables better tissue attraction and better visualization,” said Dr. Alberto Rodriguez-Navarro, the founder and CEO of Levita Magnetics, for The Post.

“In the case of the prostate, this may turn out to see the surgeon better the nerve packages,” continued rodriguez-navarro. “Nerves are very important because they are related to incontinence, such as urinary incontinence, and also sexual function, so storing those nerves is critical.”

Dr. Jeffrey Cadeddu used the only Robotic System of the Da Vinci Port and the Mars Levita platform together for the first time to remove a 67-year-old man’s prostate With prostate cancer in Phase 2 at the Southwestern UT Medical Center.

The double method reduces the number of incisions, leading to less pain, less complications, faster recovery and fewer wounds.

“Technologies made by different companies are usually not made to work together … But we can work together, this is what was interesting for this,” said Cadeddu, a Urologist, Professor and Board member Levita’s medical advisory.

In a robotic prostatectomy, a urologist makes five or Six small incisions in the lower stomach area to introduce miniature surgical tools and a camera to enter and remove the prostate gland.

The only Da Vinci port, launched in the SH.BA in 2018 by surgical intuitive, only requires a small cut because the cameras and three instruments are grouped into one shaft.

The one-wing design which Cadeddu compares to an octopus-leans a larger range of movement and minimizes clashes between the instruments.

Da Vinci provides deep and narrow access to the tissue, while the Mars system uses magnetic force to accurately tissue pull and manipulation of the internal organs.

An external magnet on the patient’s skin controls a magnetic clip inside the body.

“The actual prostate cut is done by [da Vinci] The robot, but the manipulation of the adjacent tissue is done by the magnetic robot of Mars, “Cadeddu explained.” By marrying both in one operation – two robots, one who controls Grasper, one that controls scissors and dissection from the surgeon – this is innovation. “

Mars, launched in 2023, has been used independently for weight loss operations, gall bladder removal and colorectal procedures.

The plan is to use double technology in operations beyond prostate removal and expand to other countries. Rodriguez-Navarro hopes to apply the technique to New York hospitals this year.

“We’re starting,” he said. “The idea is that we put this in the hands of all surgeons in the US and also on a worldwide scale.”